These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28410874)

  • 1. Predictivity of clinical efficacy of sublingual immunotherapy (SLIT) based on sensitisation pattern to molecular allergens in children with allergic rhinoconjunctivitis.
    di Coste A; Occasi F; De Castro G; Zicari AM; Galandrini R; Giuffrida A; Indinnimeo L; Duse M
    Allergol Immunopathol (Madr); 2017; 45(5):452-456. PubMed ID: 28410874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy alters salivary IgA and systemic immune mediators in timothy allergic children.
    Huoman J; Papapavlou G; Pap A; Alm J; Nilsson LJ; Jenmalm MC
    Pediatr Allergy Immunol; 2019 Aug; 30(5):522-530. PubMed ID: 30803044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
    JAMA Intern Med; 2015 Aug; 175(8):1301-9. PubMed ID: 26120825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
    Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
    Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE profiles of Bermuda grass pollen sensitised patients evaluated by Phleum pratense allergens Phl P 1, 2, 4, 5, 6 , 7, 11, 12.
    Rossi RE; Monasterolo G; Prina P; Coco G; Operti D; Rossi L
    Allergol Int; 2008 Jun; 57(2):157-64. PubMed ID: 18349590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy in children: the recent experiences.
    Pleskovic N; Bartholow A; Skoner DP
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):582-90. PubMed ID: 25188717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of
    López-Freire S; Méndez-Brea P; González-Fernández T; Gude F; Vidal C
    Eur Ann Allergy Clin Immunol; 2021 Jul; 53(4):185-190. PubMed ID: 32549528
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.
    Baron-Bodo V; Horiot S; Lautrette A; Chabre H; Drucbert AS; Danzé PM; Sénéchal H; Peltre G; Galvain S; Zeldin RK; Horak F; Moingeon P
    Clin Exp Allergy; 2013 Dec; 43(12):1362-73. PubMed ID: 24261946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timothy specific IgE levels are associated with efficacy and safety of timothy grass sublingual immunotherapy tablet.
    Nolte M; Barber D; Maloney J; Li Z; Kaur A; Galan A; Andersen JS; Nolte H
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):509-515.e2. PubMed ID: 26507709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.
    Didier A; Malling HJ; Worm M; Horak F; Sussman G; Melac M; Soulié S; Zeldin RK
    Clin Exp Allergy; 2013 May; 43(5):568-77. PubMed ID: 23600548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.
    Mösges R; Rohdenburg C; Eichel A; Zadoyan G; Kasche EM; Shah-Hosseini K; Lehmacher W; Schmalz P; Compalati E
    Immunotherapy; 2017 Nov; 9(15):1225-1238. PubMed ID: 29130797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis.
    Gotoh M; Kaminuma O; Nakaya A; Katayama K; Motoi Y; Watanabe N; Saeki M; Nishimura T; Kitamura N; Yamaoka K; Okubo K; Hiroi T
    Int Immunol; 2017 Jun; 29(6):291-300. PubMed ID: 28575522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais® tablets.
    Mösges R; Ritter B; Kayoko G; Allekotte S
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):3-10. PubMed ID: 20976414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Effect of the Tree Pollen SLIT-Tablet on Allergic Rhinoconjunctivitis During Oak Pollen Season.
    Nolte H; Waserman S; Ellis AK; Biedermann T; Würtzen PA
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1871-1878. PubMed ID: 33548518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal reactivity evaluation in children with allergic rhinitis receiving grass pollen sublingual immunotherapy.
    Schiavi L; Brindisi G; De Castro G; De Vittori V; Loffredo L; Spalice A; Duse M; Zicari AM
    Allergy Asthma Proc; 2020 Sep; 41(5):357-362. PubMed ID: 32867890
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
    Rolinck-Werninghaus C; Wolf H; Liebke C; Baars JC; Lange J; Kopp MV; Hammermann J; Leupold W; Bartels P; Gruebl A; Bauer CP; Schnitker J; Wahn U; Niggemann B
    Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergenic profile to Phleum pratense and immunological changes induced after grass allergen-specific immunotherapy.
    Beitia JM; López-Matas MA; Alonso A; Vega A; Mateo B; Cárdenas R; Carnés J
    Int Arch Allergy Immunol; 2014; 165(1):9-17. PubMed ID: 25277364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.